Wyeth vs. GSK: A Vaccine Showdown?
January 11, 2009 by tim · Leave a Comment
Today Biohorizon will take its first look at two new vaccines that promise to make the prevention of pneumococcal disease far more interesting and complex. Both Wyeth and GSK have advanced emerging pneumococcal conjugate vaccine candidates to the filing stage in either the United States, European Union or both. In an effort to understand and [...]